Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.

Li Y, Zhao X, Tang H, Zhong Z, Zhang L, Xu R, Li S, Wang Y.

Urol Int. 2012;88(1):95-101. doi: 10.1159/000331881. Epub 2011 Oct 25.

PMID:
22041818
2.

How does hypoxia inducible factor-1α participate in enhancing the glycolysis activity in cervical cancer?

Cheng Y, Chen G, Hong L, Zhou L, Hu M, Li B, Huang J, Xia L, Li C.

Ann Diagn Pathol. 2013 Jun;17(3):305-11. doi: 10.1016/j.anndiagpath.2012.12.002. Epub 2013 Feb 1. Review.

PMID:
23375385
3.

The intriguing interplay between therapies targeting the epidermal growth factor receptor, the hypoxic microenvironment and hypoxia-inducible factors.

Wouters A, Boeckx C, Vermorken JB, Van den Weyngaert D, Peeters M, Lardon F.

Curr Pharm Des. 2013;19(5):907-17. Review.

PMID:
22973959
4.

Recent agents targeting HIF-1α for cancer therapy.

Hu Y, Liu J, Huang H.

J Cell Biochem. 2013 Mar;114(3):498-509. doi: 10.1002/jcb.24390. Review.

PMID:
22961911
5.

Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.

Rohwer N, Cramer T.

Drug Resist Updat. 2011 Jun;14(3):191-201. doi: 10.1016/j.drup.2011.03.001. Epub 2011 Apr 3. Review.

PMID:
21466972
6.

Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.

Xia Y, Choi HK, Lee K.

Eur J Med Chem. 2012 Mar;49:24-40. doi: 10.1016/j.ejmech.2012.01.033. Epub 2012 Jan 24. Review.

PMID:
22305612
7.

Therapeutic targeting of hypoxia and hypoxia-inducible factor 1 alpha in multiple myeloma.

Borsi E, Terragna C, Brioli A, Tacchetti P, Martello M, Cavo M.

Transl Res. 2015 Jun;165(6):641-50. doi: 10.1016/j.trsl.2014.12.001. Epub 2014 Dec 11. Review.

PMID:
25553605
8.

Carrot and stick: HIF-alpha engages c-Myc in hypoxic adaptation.

Huang LE.

Cell Death Differ. 2008 Apr;15(4):672-7. doi: 10.1038/sj.cdd.4402302. Epub 2008 Jan 11. Review.

9.

Bridging hypoxia, inflammation and estrogen receptors in thyroid cancer progression.

Tafani M, De Santis E, Coppola L, Perrone GA, Carnevale I, Russo A, Pucci B, Carpi A, Bizzarri M, Russo MA.

Biomed Pharmacother. 2014 Feb;68(1):1-5. doi: 10.1016/j.biopha.2013.10.013. Epub 2013 Nov 15. Review.

PMID:
24286852
10.

[The relationship between hypoxia-inducible factor-1α and cartilage degeneration in osteoarthritis: a review].

Dong FF, Wang YJ, Zhou CJ.

Zhong Xi Yi Jie He Xue Bao. 2012 Jan;10(1):13-8. Review. Chinese.

11.

A novel approach to cancer therapy using PX-478 as a HIF-1α inhibitor.

Lee K, Kim HM.

Arch Pharm Res. 2011 Oct;34(10):1583-5. doi: 10.1007/s12272-011-1021-3. Review.

PMID:
22076756
12.

New anticancer strategies targeting HIF-1.

Yeo EJ, Chun YS, Park JW.

Biochem Pharmacol. 2004 Sep 15;68(6):1061-9. Review.

PMID:
15313402
13.

Hypoxia-inducible factor-1alpha in hepatic fibrosis: A promising therapeutic target.

Zhan L, Huang C, Meng XM, Song Y, Wu XQ, Yang Y, Li J.

Biochimie. 2015 Jan;108:1-7. doi: 10.1016/j.biochi.2014.10.013. Epub 2014 Oct 25. Review.

PMID:
25447141
14.

Hypoxia-inducible factor-1alpha: molecular-targeted therapy for hepatocellular carcinoma.

Dong ZZ, Yao M, Wang L, Wu W, Gu X, Yao DF.

Mini Rev Med Chem. 2013 Jul;13(9):1295-304. Review.

PMID:
22512580
15.

HIF-1--a big chapter in the cancer tale.

Ajduković J.

Exp Oncol. 2016 Mar;38(1):9-12. Review.

PMID:
27031712
16.

Dynamic balancing of the dual nature of HIF-1alpha for cell survival.

Koshiji M, Huang LE.

Cell Cycle. 2004 Jul;3(7):853-4. Epub 2004 Jul 25. Review.

PMID:
15190211
17.

[Role of thrombospondin-1 in hypoxia-induced migration of human vascular smooth muscle cells].

Takahashi M, Oka M, Ikeda T, Akiba S, Sato T.

Yakugaku Zasshi. 2008 Mar;128(3):377-83. Review. Japanese.

18.

HIF-1alpha and cancer therapy.

Koh MY, Spivak-Kroizman TR, Powis G.

Recent Results Cancer Res. 2010;180:15-34. doi: 10.1007/978-3-540-78281-0_3. Review.

PMID:
20033376
19.

Hypoxic regulation of mRNA expression.

Gardner LB, Corn PG.

Cell Cycle. 2008 Jul 1;7(13):1916-24. Epub 2008 Apr 24. Review.

PMID:
18604161
20.

Mechanisms of regulation of PFKFB expression in pancreatic and gastric cancer cells.

Minchenko OH, Tsuchihara K, Minchenko DO, Bikfalvi A, Esumi H.

World J Gastroenterol. 2014 Oct 14;20(38):13705-17. doi: 10.3748/wjg.v20.i38.13705. Review.

Supplemental Content

Support Center